4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-048509
Options or other derivatives
- Chief Financial Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Goeltz II Robert C. Chief Financial Officer | 2016-01-21 | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | D: show line 1 in the form |
Loading xslF345X03/doc1.xml…